Optum Rx may enter biosimilar market to match competitors CVS, Express Scripts

Top PBM Op­tum Rx may be mov­ing in­to the biosim­i­lar busi­ness, join­ing its com­peti­tors CVS and Ex­press Scripts, ac­cord­ing to a US trade­mark ap­pli­ca­tion for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.